Chromatics Color Sciences International. Inc; CCSI Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI

CCSI 24.53

-1.8%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JanyBlueEyes who wrote (3433)	6/23/1998 10:41:00 PM
From: Steve	Read Replies (2) of 5736

"Thus the use of noninvasive bilirubin determinations will not be restricted to the hospital, will likely find as much or more use in the outpatient population. As there are 132,418,000 babies born annually throughout the world (1996 data from UNICEF) it is reasonable to assume that about 90% or 119,176,200 annually will be potential subjects for a bilirubin determination. This does not strike me as being an "extremely limited" market."" Janybird: If this device is such a big deal how did the world ever survive for so many years without it. How many people have come to you and said there newborn baby died of jaundice? I may not know much about investing, if I did I would have shorted this at $15 a share, but since I am a doctor I do know medicine and I'm telling you this device is worthless. Call your pediatrician and ask them if they think every mother needs a TLc-BiliTest at home. I don't want to pick a fight with you here but you really should contact some hospitals and other doctors and see if they think this device will fly regardless of what Dr. Maisels says.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next